Ministry of Health: The scope of application of the National Essential Medicines Catalogue will be expanded to **

On November 20th, the 2012 China Pharmaceutical Congress sponsored by the China Pharmaceutical Association and the 12th China Pharmacist Week opened in Nanjing, Jiangsu Province. Minister of Health Chen Hao attended the meeting and delivered a speech. Chen Hao disclosed that the 2012 edition of the National Essential Drug List will be released this year, and its scope of application will move from basic medical institutions to large urban hospitals; the Ministry of Health is selecting the essential drugs needed for the prevention and treatment of major diseases and will include them in the national essential drug list management.

Chen Hao said that at present, the medical support for major diseases of rural residents jointly promoted by the Ministry of Health, the Joint Development and Reform Commission, the Ministry of Finance, and the Civil Administration and other related departments is constantly deepening. To ensure the smooth progress of this project that benefits ten million people's livelihood, the Ministry of Health is following The principle of prevention is necessary, safe and effective, reasonable price, easy to use, and equal emphasis on Chinese and Western medicine. Scientific selection of essential drugs required for the prevention and treatment of major diseases will be incorporated into the national basic drug list management, and drugs and consumables will be implemented according to different situations. Classification management, to achieve "a drug and a policy", the organization of the province as a unit of centralized procurement, in order to protect the quality of medicines and supplies and supplies. “One drug and one policy” refers to formulating corresponding policies for a class of drugs on the basis of drug classification management to ensure the supply of drugs.

Chen Xi pointed out that in medical reforms, pharmaceutical personnel play an important role in ensuring basic, strong grassroots, and building mechanisms, promoting rational drug use, and safeguarding the health of the people. However, there are still some problems in China, such as insufficient number of pharmaceutical talents, uneven distribution, large differences in professional quality, and weak foundation of basic pharmaceutical services. We should seize the national “Twelfth Five-Year Plan” talent development plan and take pharmacists as a good opportunity for shortage of talents. Pharmacist team development plan, pay attention to strengthen the pharmacist team construction, focus on strengthening the professional skills of rural pharmacy staff, improve the overall quality of pharmacist team.

The conference commended 72 outstanding pharmacists and six young pharmacists won the Youth Pharmaceutical Award of the Shijiazhuang Pharmaceutical Group. The key technology research and industrialization projects for the new formulation of antitumor drugs, “Paclitaxel Liposomes for Injection” by Nanjing Green Leaf Cisco Pharmaceutical Co., Ltd. and Jiangsu Provincial Institute of Pharmaceutical Research Co., Ltd., won the first prize of the Chinese Pharmaceutical Association Science and Technology Award.